The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Abstract
The Movement Disorder Society Task Force for Rating Scales for Parkinson's Disease prepared a critique of the Unified Parkinson's Disease Rating Scale (UPDRS). Strengths of the UPDRS include its wide utilization, its application across the clinical spectrum of PD, its nearly comprehensive coverage of motor symptoms, and its clinimetric properties, including reliability and validity. Weaknesses include several ambiguities in the written text, inadequate instructions for raters, some metric flaws, and the absence of screening questions on several important non‐motor aspects of PD. The Task Force recommends that the MDS sponsor the development of a new version of the UPDRS and encourage efforts to establish its clinimetric properties, especially addressing the need to define a Minimal Clinically Relevant Difference and a Minimal Clinically Relevant Incremental Difference, as well as testing its correlation with the current UPDRS. If developed, the new scale should be culturally unbiased and be tested in different racial, gender, and age‐groups. Future goals should include the definition of UPDRS scores with confidence intervals that correlate with clinically pertinent designations, “minimal,” “mild,” “moderate,” and “severe” PD. Whereas the presence of non‐motor components of PD can be identified with screening questions, a new version of the UPDRS should include an official appendix that includes other, more detailed, and optionally used scales to determine severity of these impairments. © 2003 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Clinical Significance of Reported Changes in Pain Severity☆☆☆★
Todd, K. H., Funk, K. G., Funk, J. P., & Bonacci, R. (1996) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(96)70238-x · Cited by 1,109
Gallagher, E. J., Liebman, M., & Bijur, P. E. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.118863 · Cited by 1,024
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
Defer, G.-L., Widner, H., Mari�, R.-M., R�my, P., Levivier, M., & Conference Participants: Conference Participants: G. L. Defer, M. (. (1999) · Movement Disorders · doi:10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c · Cited by 865
Unified Parkinson's disease rating scale characteristics and structure
Martínez‐Martín, P., Gil‐Nagel, A., Gracia, L. M., Gómez, J. B., Martínez‐Sarriés, J., Bermejo, F., & The Cooperative Multicentric Group (1994) · Movement Disorders · doi:10.1002/mds.870090112 · Cited by 796
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
Ramaker, C., Marinus, J., Stiggelbout, A. M., & van Hilten, B. J. (2002) · Movement Disorders · doi:10.1002/mds.10248 · Cited by 666
Parkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
(1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 615
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Jones, P. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00063702 · Cited by 585
Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00081-0 · Cited by 561
Critical analysis of the disability in Parkinson's disease.
Webster, D. D. (1968) · PubMed · Cited by 488
Seibyl, J. P., Marchek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea‐Ponce, Y., Baldwin, R. M., Fussell, B., Smith, E. O., Charney, D. S., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380407 · Cited by 467
Third symposium on Parkinson's disease
Tucker, J. S. (1970) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(70)90108-2 · Cited by 414
Clinically significant changes in pain along the visual analog scale
Bird, S. B., & Dickson, E. W. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.118012 · Cited by 368
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Interrater reliability of the unified Parkinson's disease rating scale motor examination
Richards, M., Marder, K., Cote, L., & Mayeux, R. (1994) · Movement Disorders · doi:10.1002/mds.870090114 · Cited by 318
Marinus, J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.241 · Cited by 288
Ropinirole for the treatment of early Parkinson's disease
Adler, C. H., Sethi, K. D., Hauser, R. A., Davis, T. L., Hammerstad, J. P., Bertoni, J., Taylor, R. L., Sanchez-Ramos, J., O'Brien, C. F., & Ropinirole Study Group (1997) · Neurology · doi:10.1212/wnl.49.2.393 · Cited by 281
Treatment interventions for Parkinson's disease: an evidence based assessment
Rascol, O., Goetz, C., Koller, W., Poewe, W., & Sampaio, C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08520-3 · Cited by 279
Lieberman, A., Ranhosky, A., & Korts, D. (1997) · Neurology · doi:10.1212/wnl.49.1.162 · Cited by 268
Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients
Goetz, C. G., Blasucci, L. M., Leurgans, S., & Pappert, E. J. (2000) · Neurology · doi:10.1212/wnl.55.6.789 · Cited by 249
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
Marconi, R., Lefebvre‐Caparros, D., Bonnet, A., Vidailhet, M., Dubois, B., & Agid, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090103 · Cited by 237
Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
Luquin, M. R., Scipioni, O., Vaamonde, J., Gershanik, O., & Obeso, J. A. (1992) · Movement Disorders · doi:10.1002/mds.870070204 · Cited by 235
Siderowf, A., McDermott, M., Kieburtz, K., Blindauer, K., Plumb, S., Shoulson, I., & the Parkinson Study Group (2002) · Movement Disorders · doi:10.1002/mds.10011 · Cited by 234
A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASE
CANTER, G. J., de La TORRE, R., & MIER, M. (1961) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196108000-00010 · Cited by 220
Knopman, D. S., Knapp, M. J., Gracon, S. I., & Davis, C. S. (1994) · Neurology · doi:10.1212/wnl.44.12.2315 · Cited by 213
Factor structure of the unified Parkinson's disease rating scale: Motor examination section
Stebbins, G. T., & Goetz, C. G. (1998) · Movement Disorders · doi:10.1002/mds.870130404 · Cited by 201
Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial
de Bie, R. M., de Haan, R. J., Nijssen, P. C., Rutgers, A. W. F., Beute, G. N., Bosch, D. A., Haaxma, R., Schmand, B., Schuurman, P. R., Staal, M. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03556-4 · Cited by 177
Bennett, D. A., Shannon, K. M., Beckett, L. A., Goetz, C. G., & Wilson, R. S. (1997) · Neurology · doi:10.1212/wnl.49.6.1580 · Cited by 163
Teaching tape for the motor section of the unified Parkinson's disease rating scale
Goetz, C. G., Stebbins, G. T., Chmura, T. A., Fahn, S., Klawans, H. L., & MARSDEN, C. D. (1995) · Movement Disorders · doi:10.1002/mds.870100305 · Cited by 154
van Hilten, J. J., van der Zwan, A. D., Zwinderman, A. H., & Roos, R. A. C. (1994) · Movement Disorders · doi:10.1002/mds.870090113 · Cited by 136
Goetz, C. G., Leurgans, S. E., & Raman, R. (2002) · Movement Disorders · doi:10.1002/mds.10024 · Cited by 135
Monoamines, noyaux gris centraux et syndrome de Parkinson
Stern, G. M. (1975) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(75)90147-1 · Cited by 134
The natural history of Parkinson's disease
Poewe, W. H., & Wenning, G. K. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.146s · Cited by 111
Ballard, C. G., McKeith, I. G., Burn, D. J., Harrison, R., O'Brien, J. T., Lowery, K., Campbell, M. C., Perry, R. H., & Ince, P. G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00299.x · Cited by 106
Stebbins, G. T., Goetz, C. G., Lang, A. E., & Cubo, E. (1999) · Movement Disorders · Cited by 84
Vieregge, P., Stolze, H., Klein, C., & Heberlein, I. (1997) · Journal of Neural Transmission · doi:10.1007/bf01273184 · Cited by 79
Louis, E. D., Lynch, T., Marder, K. S., & Fahn, S. (1996) · Movement Disorders · doi:10.1002/mds.870110212 · Cited by 77
Evaluation of the Short Parkinsonʼs Evaluation Scale
Rabey, J. M., Bass, H., Bonuccelli, U., Brooks, D. J., Klotz, P., Korczyn, A. D., Kraus, P., Martinez-Martin, P., Morrish, P., Sauten, W. V., et al. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199708000-00004 · Cited by 77
A New Clinical Tool for Gait Evaluation in Parkinsonʼs Disease
Martínez‐Martín, P., Urra, D. G., Quijano, T. D. S., Gomez, J., Utrero, E. G., Piñeiro, R., & Andrés, M. T. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199706000-00001 · Cited by 74
Cubo, E., Stebbins, G. T., Golbe, L. I., Nieves, A. V., Leurgans, S. E., Goetz, C. G., & Kompoliti, K. (2000) · Movement Disorders · Cited by 60
Discriminating mild parkinsonism: Methods for epidemiological research
Camicioli, R. M., Grossmann, S. J., Spencer, P. S., Hudnell, K., & Anger, W. K. (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<33::aid-mds1014>3.0.co;2-w · Cited by 60
Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease
McDermott, M., Jankovic, J. J., Carter, J., Fahn, S., Gauthier, S. G., Goetz, C. G., Golbe, L. I., Koller, W. C., Lang, A. E., Olanow, C. W., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300037010 · Cited by 59
Rating scales for dyskinesias in Parkinson's disease.
Cg, G. (1999) · PubMed · Cited by 42
Oremus, M., Perrault, A., Demers, L., & Wolfson, C. M. (2000) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870001300404 · Cited by 34
A double‐blind comparison of levodopa, madopa, and sinemet in Parkinson disease
Diamond, S. G., Markham, C. H., & Treciokas, L. J. (1978) · Annals of Neurology · doi:10.1002/ana.410030314 · Cited by 27
Placebos, active control groups, and the unpredictability paradox
Mattocks, K. M., & Horwitz, R. I. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00839-8 · Cited by 24
Martínez‐Martín, P., Fontan, C., Payo, B. F., & Petidier, R. (2000) · PubMed · Cited by 20
Hogan, T., Grimaldi, R., Dingemanse, J., Martin, M., Lyons, K. E., & Koller, W. C. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00023-1 · Cited by 13
Cited by
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Goetz, C. G., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R., Dubois, B., et al. (2007) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,404
Stebbins, G. T., Goetz, C. G., Burn, D. J., Jankovic, J., Khoo, T. K., & Tilley, B. C. (2013) · Movement Disorders · doi:10.1002/mds.25383 · Cited by 932
Metadata
- Authors
- Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2003-06-12
- Volume
- 18
- Issue
- 7
- Pages
- 738-750
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4249888301
- Cited by
- 1,810
- References
- 52
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.